UNSPSC 85814716: Introduction of monoclonal antibody into female reproductive, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into female reproductive, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0P30M

UNSPSC 85814716 (Introduction of monoclonal antibody into female reproductive, percutaneous approach) is a Commodity code that does not map to active state and local procurement activity. The recent opportunities tagged under this code span virtual urgent care, medical services, program operations for elderly populations, occupational health, cancer screening, mental health services, EMS operations, and administrative wellness platforms — none of which involve the delivery of monoclonal antibody treatments. The code's nominal scope — a clinical procedure involving therapeutic immunology — appears unrelated to the substantive work being solicited by state and local issuers, suggesting either a cataloging mismatch in the source data or minimal recent demand for the specific service this code describes.

The issuing bodies in the tagged opportunities include state health authorities (Nevada Health Authority), county governments (DeKalb County, Brevard County, Santa Clara County, Forsyth County, Seminole County, and others), cities (Atlanta, Phoenix, Ocala, Boulder), and special healthcare districts (San Mateo Medical Center, Inland Empire Health Plan). Geographically, recent procurement activity under or near this code appears concentrated in California, Georgia, Nevada, and Florida, with additional activity across Colorado, Kansas, Missouri, Texas, and other states. Because the Commodity code itself shows little relevant recent activity aligned with its stated definition, this code presents minimal near-term opportunity for vendors specializing in reproductive-system monoclonal antibody delivery.